Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study
Abstract Background Ischemic stroke and transient ischemic attack (TIA) are the most prevalent cerebrovascular diseases. The conventional antiplatelet drugs are associated with an inherent bleeding risk, while indobufen is a new antiplatelet drug and has the similar mechanism of antiplatelet aggrega...
Main Authors: | Xudong Liu, Xuxian Lv, Yanfang Peng, Jianing Wang, Junjie Lei, Chaogang Tang, Shijian Luo, Weihua Mai, Yiming Cai, Qian Fan, Chenhao Liu, Lei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12883-024-03585-4 |
Similar Items
-
Effectiveness of Platelet Function Analysis-Guided Aspirin and/or Clopidogrel Therapy in Preventing Secondary Stroke: A Systematic Review and Meta-Analysis
by: Ann-Rong Yan, et al.
Published: (2020-12-01) -
Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
by: Leonardo De Luca, et al.
Published: (2021-04-01) -
Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack
by: Zixiao Li, et al.
Published: (2016-03-01) -
THE EFFECT OF LOW DOSE ASPIRIN ON BLEEDING IN PATIENTS UNDERGOING MINOR ORAL SURGICAL PROCEDURES
by: Babar Pasha, et al.
Published: (2018-04-01) -
Appropriate use of antiplatelet medications following transient ischemic attacks and stroke: a 9-year study from the Middle East
by: Hiba Naveed, et al.
Published: (2023-11-01)